<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of the <z:chebi fb="0" ids="37961">H2 receptor antagonists</z:chebi>, <z:chebi fb="1" ids="3699">cimetidine</z:chebi> and <z:chebi fb="10" ids="8776">ranitidine</z:chebi>, on <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was assessed in a retrospective study </plain></SENT>
<SENT sid="1" pm="."><plain>There was no evidence of regression of Barrett's epithelium in the 22 patients treated for a mean of 13 months with 800-1,600 mg/day <z:chebi fb="1" ids="3699">cimetidine</z:chebi>, or in the 13 patients treated for a mean of 5.7 months with 300 mg/day <z:chebi fb="10" ids="8776">ranitidine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Eight of 12 esophageal (Barrett's) <z:mpath ids='MPATH_579'>ulcers</z:mpath> healed on <z:chebi fb="1" ids="3699">cimetidine</z:chebi> therapy over a mean period of 8.7 months, and eight of nine <z:mp ids='MP_0004547'>esophageal ulcers</z:mp> healed on <z:chebi fb="10" ids="8776">ranitidine</z:chebi> therapy over a mean period of 3.5 months </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that short-term treatment with H2 blockade does not cause regression of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, although such treatment can heal <z:mp ids='MP_0004547'>esophageal ulcers</z:mp> </plain></SENT>
</text></document>